Study Shows Cancer Vaccines Led to Long-Term Survival for Patients with Metastatic Melanoma and to Long Periods of Disease Control After Completion of Therapy
...
The study entitled "Phase II Trial of
dendritic Cells Loaded with Antigens from Self-Renewing, ... a total of up to eight injections. The patient's
dendritic cells were obtained from their peripheral blood ... (64 vs. 31 months, p=.016). Eight patients in the
dendritic cell vaccine study experienced remarkable ...
CEL SCI Collaborators Demonstrate Novel L.E.A.P.S. Vaccines Immunize Mice Against Tuberculosis Antigens and Suggest Potential to Treat Swine and Other Influenzas
... vaccines can activate and cause human immature
dendritic cells from blood monocyte cells to become
dendritic cells that secrete the IL-12 cytokine. The
dendritic cells that result initiate a protective cell ...
Agennix Receives Fast Track Designation From FDA for Talactoferrin in Combination With Sunitinib for Renal Cell Carcinoma
...
Talactoferrin is a novel targeted
dendritic cell recruiter and activator (DCRA) being studied ... mediates its anti-cancer activity by targeting
dendritic cells which play an important role in activating ... talactoferrin induces the recruitment of immature
dendritic cells to the GALT and promotes their maturation. ...
Studies Presented at AACR Annual Meeting Highlight Multiple Immunomodulatory Mechanisms of Peregrine's PS-Targeting Antibodies
... Peregrine's PS-Targeting Antibodies Stimulate
dendritic Cell Maturation, Inflammatory Cytokine and ... antibody PGN632 to promote the maturation of
dendritic cells, important antigen-presenting cells of the ... system. In the in vitro studies, immature
dendritic cells cultured in the presence of PGN632 ...
Novel Valortim(R) Mechanism of Action Data Presented at the Keystone Symposia on Molecular and Cellular Biology
... on Molecular and Cellular Biology Conference on
dendritic Cells, March 29-April 3, 2009 in Banff, Alberta. ... on March 30th entitled MAb-Enhanced, Human
dendritic Cell-Mediated Adaptive Immune Response to B. ... can enhance the killing of anthrax by human
dendritic cells.
Dr. Cross remarked, "These latest ...
Update of Long-Term Data on Brain Cancer Patients Receiving DCVax(R)-Brain Continues to Show Striking Improvements in Delay of Disease and Survival
... surgery as
part of the current standard of care.
dendritic cells drawn from a sample of
the patient's blood ... weeks apart and then months apart. These
dendritic cells are then able
to mobilize the immune system ... The Company has two
broad platform technologies:
dendritic cell-based vaccines and therapeutic
antibodies. ...
Long-Term Phase I and Phase I/II Trial Data Continue to Show Striking Improvement in Survival of Brain Cancer Patients Who Receive DCVax(R)-Brain
... surgery as part of the current Standard of
Care.
dendritic cells drawn from a sample of the patient's blood ... and
"educated." These activated and "educated"
dendritic cells are injected
back into the patient, in a ... several weeks
apart and then months apart. These
dendritic cells are then able to
mobilize the immune system ...
Results Published in the Journal 'Cancer' Demonstrate that Oral Talactoferrin Alfa is Active as Monotherapy in Previously Treated Patients with Metastatic Renal Cell Carcinoma
... About Talactoferrin Alfa
Talactoferrin, a novel
dendritic cell recruiter and activator (DCRA),
is a unique ... in the
body. It acts through a novel mechanism of
dendritic cell recruitment and
activation. Following oral ... Patches, where it recruits
circulating immature
dendritic cells bearing tumor antigens to the GALT ...
Journal of Clinical Oncology Publishes Leukine(R) Study Demonstrating Positive Survival Outcomes in Patients with High-Risk Melanoma
... - Phase II Trial Shows Increase in Mature
dendritic Cells -
WAYNE, N.J., June 30 ... of 65 months and increased mature
dendritic cells in high-risk
melanoma patients.
dendritic cells are special antigen-presenting cells
that ...
Oral Talactoferrin Alfa Improves Overall Survival in Patients With Refractory Non-Small Cell Lung Cancer: Final Phase 2 Study Results Presented at the 8th Annual Targeted Therapies for the Treatment Of Lung Cancer Meeting
... About Talactoferrin Alfa
Talactoferrin, a novel
dendritic cell activator (DCA), is a unique
recombinant ... in the
body. It acts through a novel mechanism of
dendritic cell recruitment and
activation. Following oral ... Patches, where it recruits
circulating immature
dendritic cells bearing tumor antigens to the GALT ...
Phase I and Phase I/II DCVax(R)-Brain Data Continues to Show Significantly Improved Survival Rates for Brain Cancer Patients
... DCVax(R)-Brain is
made up of the patient's own
dendritic cells that have been "educated" to
recognize and ... surgery as part of the
current Standard of Care.
dendritic cells drawn from a sample of the
patient's blood ... and "educated." These
activated and "educated"
dendritic cells are injected back into the
patient, in a ...
Northwest Biotherapeutics Conducting Ovarian Cancer Clinical Trial With DCVax(R)-L at University of Pennsylvania
... for cancer, which is made
from a patient's own
dendritic cells (the master cells which initiate and
manage ... biomarkers are then loaded onto the
patient's own
dendritic cells (the master cells responsible for ... The
Company has two broad platform technologies:
dendritic cell-based vaccines,
and therapeutic antibodies. ...
Affitech-Discovered Anti-PS Antibodies in Development by Peregrine Pharmaceuticals Show Excellent Functionality in Preclinical Studies
... collaborators) and Affitech demonstrated in in vitro
studies that immature
dendritic cells cultured in the presence of PGN632
exhibited a significant increase ... in the expression of
cell-surface molecules that are indicative of mature
dendritic cells and that
assist in antigen presentation functions, as well as in ...
Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress
... significant cytokine and chemokine production; -- Poly-ICR matures
dendritic cells, known as "the teachers of the immune system".
In addition to ... novel and potent
immunomodulator works with the immune system to induce
dendritic cell
maturation, along with a broad range of inflammatory cytokines ...
Study Supports Possible Use of Leukine(R) as a Potential Adjuvant Therapy for High-Risk Melanoma Patients
... by Leukine and IL-2 (p=.8), and there was
no increase in the number of
dendritic cells during or after Leukine
administration in the 11 patients who donated blood for
dendritic cell
counts.
About Leukine(R)
Leukine(R) (sargramostim) is a growth ...
IDM Pharma Announces Updated Phase 2 UVIDEM(R) Results Showing Durable Disease Control and Tolerability in Advanced Melanoma Patients
... and the incidence and
severity of adverse events of a multivalent
dendritic cell-based vaccine
(UVIDEM) in patients with in-transit or low volume ... marketing rights to UVIDEM in
melanoma. UVIDEM consists of mature
dendritic cells loaded with lysates
from melanoma tumor cell lines. UVIDEM is ...
VioQuest Pharmaceuticals Completes Enrollment of Phase I Trial of Lenocta(TM)
... Chief Scientific Officer, stated,
"The increased function in T, NK, and
dendritic cell populations at a dose
that is well tolerated is exactly what we had ... the body's immune system, through
improved cytokine signaling, T-cell and
dendritic cell functions indicate
that Lenocta(TM) has potentials as an anti-cancer ...
BioInformatics, LLC New Report - Capitalizing on New Opportunities for Stem Cell Products, Now Available
... increasing interest over the next couple of years. By 2011, osteogenic cells in particular, but also endothelial, cardiomyocytes, chondrocytes, and
dendritic cells are projected to be differentiated states as common as hematopoeitic and epithelial cells. These findings have implications for product ...
Doctors Urge Precaution to Shield Against Swine Flu
... NK cell activity in people with low NK cell function, improving the coordination of many aspects of immune response, including the interaction of
dendritic macrophage cells, T-cells and B-cells, resulting in improved health.
The benefit of AHCC's NK Cell supporting effect, and its role in defense ...
Study Demonstrates that AHCC(R) Enhances Immune System by Increasing the Production of Key Dendritic Cells
... Medical University in Osaka, Japan has shown that AHCC (Active Hexose Correlated Compound) enhances immune function by increasing the number of
dendritic cells (DCs). DCs are a key part of the immune system responsible for presenting foreign substances to other immune system cells.
The study was ...
Nventa Develops Proprietary Vaccine Adjuvant
... and prophylactic areas of
immunotherapy and vaccine development. This novel and potent
immunomodulator works with the immune system to induce
dendritic cell
maturation, along with a broad range of inflammatory cytokines and
chemokines, to facilitate the prevention and treatment of infectious
diseases ...
TARGETED GENE DELIVERY SIGNALS CANCER VACCINATION IN VIVO: Intravenous Infusions of Rexin-G Followed by Reximmune-C Induce Tumor Necrosis and Recruitment of Tumor Infiltrating Lymphocytes in Cancerous Lesions (ASCO 2008)
... tumor necrosis and
tumor infiltrating lymphocytes (TILs) were observed within the tumors.
Characterization of the recruited TILs showed CD35+
dendritic cells, CD8+
killer T cells, and CD138+ plasma B cells, with lesser amounts of CD68+
macrophages and CD20+ B cells, suggesting a relatively mature or ...
Quantum Immunologics, Inc. and the South Alabama Medical Science Foundation Announce an Early Clinical Evaluation of a Novel Immuno-therapeutic Vaccine for Treating Advanced Human Breast Carcinomas
... local oncology centers in and around
Mobile, Alabama.
The investigators will collect from each patient's blood a white blood
cell population called
dendritic Cells (DC). These cells are then exposed
in vitro to replicated iLRP, cultured, and reintroduced into the patient
via subdermal injection. The hope ...
Agennix Initiates A Randomized Double-Blind, Placebo-Controlled Phase 2 Study of Oral Talactoferrin in Severe Sepsis
... of
Xigris(R), treatment for severe sepsis remains an area of significant unmet
medical need.
About Talactoferrin Alfa
Talactoferrin, a novel
dendritic cell recruiter and activator (DCRA),
is a unique recombinant form of human lactoferrin, an important
immunomodulatory protein. Talactoferrin is an ...
Genetic Immunity Presents Clinical Data on DermaVir Patch Immune Therapy at 15th Annual Conference on Retroviruses and Opportunistic Infections
... of HIV antigens, allowing a broad immune
response. DermaPrep is a topical administration device by which NanoComp is
delivered specifically into the
dendritic cells.
Contacts:
The Ruth Group Investors Sara Ephraim +1-646-536-7002 sephraim@theruthgroup.com
Media Janine McCargo +1-646-536-7033 ...
New Patent Awarded for Antigen-Sparing Vaccines that Elicit Robust Immunity
... together with antigens from specific pathogens.
Studies in animals demonstrate these vaccines easily penetrate the
mucous membrane, where
dendritic cells rapidly engulf the antigen and
present it to the immune system. This rapid awakening of the immune system
via the intranasal route negates the ...
Celldex Therapeutics Receives Fast-Track Designation for CDX-110, a Novel EGFRvIII Vaccine for Glioblastoma
... Celldex's proprietary technology platform uses fully human
monoclonal antibodies administered directly to patients to target and
stimulate
dendritic cells - key cells within the immune system. The Company
is headquartered in Phillipsburg, New Jersey. On October 22, 2007, Celldex
and AVANT ...
Celldex Therapeutics Announces Orphan Drug Designation for CDX-110, a Novel EGFRvIII Vaccine for Glioblastoma Multiforme
... Celldex's proprietary technology platform uses fully human
monoclonal antibodies administered directly to patients to target and
stimulate
dendritic cells - key cells within the immune system. The Company
is headquartered in Phillipsburg, New Jersey. On October 22, 2007, Celldex
and AVANT ...
VioQuest Pharmaceuticals Announces Dosing of First Patient in Phase IIa Solid Tumor Study for Lenocta(TM), a Novel Protein Tyrosine Phosphatase Inhibitor
... demonstrated
pharmacodynamic activity in some solid tumors as demonstrated by increases
in the activities of natural killer cells, CD8 and type II
dendritic cells.
About Lenocta
Lenocta, a pentavalent antimonial originally used for the treatment of
the parasitic disease leishmaniasis, is an inhibitor ...
Coley Pharmaceutical Group Diversifies Pipeline with First-in-Class TLR Antagonist for the Treatment of Systemic Lupus Erythematosus
... present within B cells, which secrete high levels of interferon-alpha
and contribute to disease severity. TLR8 is expressed in monocytes and
other
dendritic cells, which are thought to produce proinflammatory
cytokines, which further contribute to disease process. Other studies have
indicated that ...
IDM Pharma Announces UVIDEM(R) and EP-2101 Data Presentations at
2007 ASCO Annual Meeting
... responses in patients with malignant
melanoma treated with a
dendritic cell-based vaccine. Preliminary
report from a multi-institutional ... marketing rights to UVIDEM in melanoma. UVIDEM consists
of mature
dendritic cells loaded with lysates from melanoma tumor
cell lines. UVIDEM is ...
IDM Pharma Presents Preliminary Results from Phase II UVIDEM
Melanoma Vaccine Clinical Trial
... clinical and immunological activities and the safety of a
multivalent
dendritic cell-based vaccine in patients with
in-transit or low volume metastatic ... marketing rights to UVIDEM in melanoma. UVIDEM consists
of mature
dendritic cells loaded with lysates from melanoma tumor
cell lines. UVIDEM is ...
MaxCyte and Medinet to Present at the 13th Annual Meeting of the
International Society for Cellular Therapy (ISCT) in Sydney,
Australia
... "Electroloading of mature
dendritic cells with tumor lysate
triggers robust antigen-specific CTL response"
... cGMP compliant manufacturing process and the resulting
production of
dendritic cell (DC) vaccines with enhanced potency as
demonstrated by higher ...
Anadys Reports Preclinical Data Showing ANA773 Promotes Anti-Tumor
Activity of Natural Killer Cells
... other immune cells. NK cells are activated by diverse
signals, including type I interferons. Large amounts of type I IFN
are produced by plasmacytoid
dendritic cells (pDCs) upon engagement
of the pattern recognition receptor TLR7. The natural ligand for
TLR7 is single stranded RNA, although a variety of ...
Data Presented at AACR Meeting Show Peregrine's Bavituximab
Equivalent Can Generate Curative Immune Responses as Part of a
Vaccine-Like Regimen in Preclinical Models of Aggressive Brain
Cancer
... system. In these studies, the animals receiving 2aG4-treated
irradiated cells showed increased antigen presentation of PS
positive tumor cells by
dendritic cells, as well as an increase in
the number of cytotoxic T cells enabling the animals' immune
systems to attack the tumor cells directly. These ...
MedImmune Publishes New Data in Nature Immunology Demonstrating The
Role HMGB1 May Play in Systemic Autoimmune Diseases
... by HMGB1
and RAGE," contains data showing that HMGB1 is a key component of
DNA-immune complexes that stimulate activation of B cells and
plasmacytoid
dendritic cells (pDCs) via the toll-like receptor 9
pathway (TLR9). Both B cells and pDCs are associated with immune
system disorders such as lupus. The data ...
Argos Therapeutics Presents Immunosuppression Data for Soluble CD83
at the American Society of Transplantation Congress 2007
... using the Company's "Arcelis" technology,
trains the immune system to recognize and attack the disease.
Argos' scientific leadership in RNA-loaded
dendritic cells and
advanced manufacturing processes provide a platform to tackle
virtually all forms of cancers and infectious ....
Introgen and Clinical Collaborators to Report New Results with
Advanced-Stage Cancer Therapies at Upcoming Medical Meetings
...
-- Final results of a phase II trial of patients with extensive
stage small cell lung cancer (ES-SCLC) immunized with wild type
-p53 transduced
dendritic cells after first-line chemotherapy,
Abstract #3012: Poster presentation on Sun., June 3, from 2:00 -
6:00 p.m. in room S102a at McCormick Place, by ...